WFSBP 2021 Preliminary Program

26 WFSBP 2021 Preliminary Scientific Program / Symposia T57: STIMULATION METHODS (e.g., ECT, TMS, VNS, DBS) S-50 15:00–16:30 Electroconvulsive therapy beyond depression: Specific populations and (yet) rare indications Chair: David Zilles-Wegner, Germany Co-Chair: Alexander Sartorius, Germany S-50-001 ECT and neurodegenerative disorders Alexander Sartorius, Germany S-50-002 ECT in Post-traumatic Stress Disorder Ulrike Schmidt, Germany S-50-003 ECT in pregnancy David Zilles-Wegner, Germany S-50-004 ECT in child and adolescent psychiatry Henrik Uebel-von Sandersleben, Germany T1: ADDICTIVE DISORDERS S-51 18:30–20:00 Behavioral addictions: Brain imaging findings and their translation to clinical practice Chair: Marc Potenza, USA Co-Chair: Florence Thibaut, France S-51-001 Internet gaming disorder: Treatment, neurobiology and gender considerations Marc Potenza, USA S-51-002 The association between excessive use of screens and cognition, emotion and the brain Aviv Weinstein, Israel S-51-003 Neural activity in individuals with buying-shopping disorder during presentation of shopping-related cues Matthias Brand, Germany S-51-004 Chemsex and compulsive sexual behaviors Florence Thibaut, France T26: MOLECULAR NEUROBIOLOGY S-52 18:30–20:00 Biomarkers of response to IV Ketamine for depression Chair: Sagar Parikh, USA Co-Chair: Susannah Tye, Australia S-52-001 Insulin-stimulated mTOR activation and antidepressant response to Ketamine Susannah Tye, Australia S-52-002 Clinical biomarkers of response to Ketamine Gregor Hasler, Switzerland S-52-003 Does inflammation mediate Ketamine response? Analysis of kynurenine metabolites and cytokines in patients receiving Ketamine Lena Brundin, USA S-52-004 The Kynurenine Pathway: Implications for mood disorders and suicidality Sophie Erhardt, Sweden T10: CHRONOBIOLOGY AND PSYCHIATRY S-53 18:30–20:00 Chronobiology: From basic concepts to clinical practice in Mood Disorders Chair: Serge Beaulieu, Canada Co-Chair: Outi Linnaranta, Finland S-53-001 There will be light! Standardizing Melatonin, actigraphy and clinical measures in Bipolar Disorders research: Recommendations from the ISBD Chronobiology Task Force Benicio N. Frey, Canada S-53-002 Clinical correlates of disrupted circadian rhythm in Bipolar Disorders Outi Linnaranta, Finland S-53-003 Personalization of the treatment to the “sleep” dimension Pierre Alexis Geoffroy, France S-53-004 Are we ready to use chronobiology in our practice? Serge Beaulieu, Canada WED